Page last updated: 2024-10-23

azathioprine and Cerebral Arterial Diseases

azathioprine has been researched along with Cerebral Arterial Diseases in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Cerebral Arterial Diseases: Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bryant, GL1
Weinblatt, ME1
Rumbaugh, C1
Coblyn, JS1

Other Studies

1 other study available for azathioprine and Cerebral Arterial Diseases

ArticleYear
Cerebral vasculopathy: an analysis of sixteen cases.
    Seminars in arthritis and rheumatism, 1986, Volume: 15, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Blood Sedimentation; Cerebral Angiography; Cereb

1986